These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26447979)

  • 1. Inhibition of Noninfectious Uveitis Using Intravenous Administration of Collagen II-Specific Type 1 Regulatory T Cells.
    Asnagli H; Jacquin M; Belmonte N; Gertner-Dardenne J; Hubert MF; Sales A; Fall PB; Ginet C; Marchetti I; Ménard F; Lara G; Bobak N; Foussat A
    Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6456-66. PubMed ID: 26447979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis.
    Asnagli H; Martire D; Belmonte N; Quentin J; Bastian H; Boucard-Jourdin M; Fall PB; Mausset-Bonnefont AL; Mantello-Moreau A; Rouquier S; Marchetti I; Jorgensen C; Foussat A; Louis-Plence P
    Arthritis Res Ther; 2014 May; 16(3):R115. PubMed ID: 24886976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of antigen-specific Treg cells in treating autoimmune uveitis via bystander suppressive pathways without compromising anti-tumor immunity.
    Chen Z; Zhang T; Kam HT; Qiao D; Jin W; Zhong Y; Zhou M; Zhou H; Chong WP; Chen W; Chen J
    EBioMedicine; 2021 Aug; 70():103496. PubMed ID: 34280776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
    Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells and IL-17A levels in noninfectious uveitis.
    Guedes MCE; Arroz MJ; Martins C; Angelo-Dias M; Proença RD; Borrego LM
    Graefes Arch Clin Exp Ophthalmol; 2020 Jun; 258(6):1269-1278. PubMed ID: 32200408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Uveitis by In Situ Administration of Ex Vivo-Activated Polyclonal Regulatory T Cells.
    Grégoire S; Terrada C; Martin GH; Fourcade G; Baeyens A; Marodon G; Fisson S; Billiard F; Lucas B; Tadayoni R; Béhar-Cohen F; Levacher B; Galy A; LeHoang P; Klatzmann D; Bodaghi B; Salomon BL
    J Immunol; 2016 Mar; 196(5):2109-18. PubMed ID: 26826251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity.
    Zhang X; Ren X; Li G; Jiao C; Zhang L; Zhao S; Wang J; Han ZC; Li X
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3143-52. PubMed ID: 21296818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
    Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment With FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis.
    Liu YH; Mölzer C; Makinen K; Kamoi K; Corbett CLC; Klaska IP; Reid DM; Wilson HM; Kuffová L; Cornall RJ; Forrester JV
    Front Immunol; 2020; 11():2071. PubMed ID: 33013877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive properties of regulatory T cells generated by incubation of peripheral blood mononuclear cells with supernatants of human RPE cells.
    Imai A; Sugita S; Kawazoe Y; Horie S; Yamada Y; Keino H; Maruyama K; Mochizuki M
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7299-309. PubMed ID: 23036994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of experimental autoimmune uveoretinitis by regulatory dendritic cells in mice.
    Usui Y; Takeuchi M; Hattori T; Okunuki Y; Nagasawa K; Kezuka T; Okumura K; Yagita H; Akiba H; Goto H
    Arch Ophthalmol; 2009 Apr; 127(4):514-9. PubMed ID: 19365033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-γ agonist pioglitazone suppresses experimental autoimmune uveitis.
    Okunuki Y; Usui Y; Nakagawa H; Tajima K; Matsuda R; Ueda S; Hattori T; Kezuka T; Goto H
    Exp Eye Res; 2013 Nov; 116():291-7. PubMed ID: 24107513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of exogenous interleukin-2, interleukin-23 on differentiation of IRBP 1-20-specific T cells toward Th1 and Th17 and comparison of the pathogenicity of IRBP 1-20-specific T cells].
    Li Y; Cui Y; Bi HS; Wang Y; Li J; Wang XR
    Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):224-9. PubMed ID: 23866703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulation of antigen specific Th17 cells differentiation in experimental autoimmune uveitis].
    Chen HT; Wang H; Zhao M; Hou B
    Zhonghua Yan Ke Za Zhi; 2012 Mar; 48(3):234-40. PubMed ID: 22800421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
    Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
    Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
    Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
    Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CII-specific autoimmune T-cell response develops in the presence of FTY720 but is regulated by enhanced Treg cells that inhibit the development of autoimmune arthritis.
    Miller DC; Whittington KB; Brand DD; Hasty KA; Rosloniec EF
    Arthritis Res Ther; 2016 Jan; 18():8. PubMed ID: 26757712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis.
    Tasso R; Ilengo C; Quarto R; Cancedda R; Caspi RR; Pennesi G
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):786-93. PubMed ID: 22232435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.